Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
University College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Reading Featured PhD Programmes
"transgenic"×
10 miles

transgenic PhD Projects, Programs & Scholarships

We have 43 transgenic PhD Projects, Programs & Scholarships

  • "transgenic" ×
  • clear all
Order by 
Showing 1 to 10 of 43
  Understanding embryonic development of complex anatomy with novel reporter transgenic chickens and single cell sequencing
  Dr M Davey, Dr J Rainger
Application Deadline: 20 January 2019
For project description and full application procedures please go to. https://www.ed.ac.uk/roslin/postgraduate/studentships/understanding-embryonic-development-of-complex-anatomy-with-novel-reporter-transgenic-chickens-and-single-cell-sequencing.
  Defining the metabolic determinants of intestinal stem cell homeostasis
  Dr A Rufini, Prof F Giorgini
Application Deadline: 6 January 2019
The intestine is the fastest renewing organ. This ability is enabled by the presence of fast proliferating intestinal stem cells (ISCs) that reside in the crypts of Lieberkühn at the base of the intestinal villi.
  MRC DiMeN Doctoral Training Partnership: Determining how mRNA turnover and translation contributes towards age-associated joint diseases
  Dr S Tew, Dr J Aspden, Prof G Bou-Gharios
Application Deadline: 21 January 2019
As our population ages it there is a significant increase in the incidence of chronic musculoskeletal diseases such as osteoarthritis.
  Targeting TFEB to correct autophagy/lysosomal deficits in Parkinson’s disease
  Prof R Wade-Martins
Application Deadline: 11 January 2019
Commercial partner. Biogen, Cambridge, Massachusetts, USA. Parkinson’s disease is the second most common neurodegenerative disorder but disease-modifying therapies are still lacking.
  B cell development and immune regulation: understanding B cell development and diseases associated with abnormal antibody production
  Prof R Cornall, Prof S Davis
Application Deadline: 11 January 2019
Our aims are to understand B cell development and diseases associated with abnormal antibody production. Inadequate or excessive immune responses lead to immunodeficiency or autoimmune and inflammatory diseases, which place a major economic and social burden on world health and the quality of human life.
  PhD project on Epigenetic Mechanisms in Neuroscience: uncovering the role of three dimensional chromatin organization
  Dr E Elliott
Applications accepted all year round
We are seeking an enthusiastic student for a novel project on the epigenetic basis of behavior. The goal of the project, under the direct supervision of Dr.
  Defining the role of p53 in cancer immunotherapy
  Prof Y. Haupt, Dr S. Haupt, Dr P. Neeson
Applications accepted all year round
Despite clear evidence of an association between the tumour suppressor p53 and immunity, a gap in knowledge exists regarding its role in modulating immune responses, or its value in predicting patient responses to immunotherapy.
  Exploration of novel approaches to anti-cancer treatment: manipulation of mutant p53
  Prof Y. Haupt, Dr S. Haupt
Applications accepted all year round
P53 is the most mutated gene in human cancer, affecting about half the cases of human cancer. We have recently identified novel regulators of mutant p53 using sophisticated loss of function whole genome high through put screen (image 1).
  Queen Mary University of London and A*STAR PhD Studentship: Investigating Immune micro-environment in pancreatic cancer
  Research Group: Barts Cancer Institute
  Dr HM Kocher
Application Deadline: 1 March 2019
This PhD programme is a collaboration between A*STAR and Queen Mary University of London (QMUL) to provide research opportunities for PhD students at A*STAR Research Institutes.
  Development of gene therapies for muscular dystrophies
  Dr L Popplewell
Applications accepted all year round
The activities in the Popplewell lab focus on the development of pre-clinical gene therapies for neuromuscular diseases, in particular muscular dystrophies based on gene replacement, endonuclease-mediated gene editing, antisense oligonucleotide (AO)-induced exon skipping and gene sliencing.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.